| Q64785682 | Q64785682 |
| Q35452165 | (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease |
| Q24678586 | A specific clinical pattern of camptocormia in Parkinson's disease |
| Q77095806 | Abnormal skin wrinkling in the less affected side in hemiparkinsonism-a possible test for sympathetic dysfunction in Parkinson's disease |
| Q51712658 | Abnormalities of rate-corrected QT intervals in Parkinson's disease-a comparison with multiple system atrophy and progressive supranuclear palsy. |
| Q46361020 | Accumulation of HtrA2/Omi in neuronal and glial inclusions in brains with alpha-synucleinopathies |
| Q35138501 | Aggregation of α-synuclein in S. cerevisiae is associated with defects in endosomal trafficking and phospholipid biosynthesis |
| Q48566508 | Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects |
| Q48352469 | An early cytoplasmic change before Lewy body maturation: an ultrastructural study of the substantia nigra from an autopsy case of juvenile parkinsonism |
| Q72848189 | Atypical senile dementia with widespread Lewy type inclusion in the cerebral cortex |
| Q33591893 | Autonomic nervous system dysfunction in Parkinson's disease: relationships with age, medication, duration, and severity |
| Q37854912 | Autophagic pathways in Parkinson disease and related disorders |
| Q67977335 | Cardiovascular reflexes and autonomic dysfunction in Parkinson's disease |
| Q90240136 | Cell models of lipid-rich α-synuclein aggregation validate known modifiers of α-synuclein biology and identify stearoyl-CoA desaturase |
| Q36928061 | Changes in the sympathetic innervation of the gut in rotenone treated mice as possible early biomarker for Parkinson's disease |
| Q48852737 | Cortical changes in the parkinsonian brain: a contribution to the delineation of "diffuse Lewy body disease". |
| Q33894382 | Critical role of truncated α-synuclein and aggregates in Parkinson's disease and incidental Lewy body disease |
| Q41589030 | Current concepts and controversies in the pathogenesis of Parkinson's disease dementia and Dementia with Lewy Bodies. |
| Q40095790 | Dense core vesicles around the Lewy body in incidental Parkinson's disease: an electron microscopic study |
| Q48824381 | Dense microspheres in normal human brain |
| Q38051969 | Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson's disease-related dementia |
| Q64768179 | Element analysis of Lewy and adrenal bodies in Parkinson's disease by electron probe microanalysis |
| Q43819951 | Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. |
| Q30607522 | Formation of α-synuclein Lewy neurite-like aggregates in axons impedes the transport of distinct endosomes |
| Q40137936 | Idiopathic parkinsonism with lewy-type inclusions in cerebral cortex. A case report |
| Q44016007 | Immunocytochemical localization of synaptic vesicle-specific protein in lewy body-containing neurons in Parkinson's disease |
| Q41837152 | Impaired baroreflex function in mice overexpressing alpha-synuclein |
| Q50109111 | Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson's disease patients |
| Q48738928 | Lewy Bodies of Parkinson's Disease Contain Neurofilament Antigens |
| Q48921589 | Lewy body pathology involves cutaneous nerves |
| Q38003064 | Lewy pathology and neurodegeneration in premotor Parkinson's disease |
| Q49111671 | Light- and electron-microscopic studies of intracytoplasmic acidophilic granules in the human locus ceruleus and substantia nigra |
| Q47801119 | Loss of native α-synuclein multimerization by strategically mutating its amphipathic helix causes abnormal vesicle interactions in neuronal cells |
| Q47818080 | Lysia K.S. Forno, MD February 14, 1918-May 8, 2015. |
| Q28389111 | Metabolism and possible health effects of aluminum |
| Q48243150 | Motor neuron disease, parkinsonism and dementia. Report of a case with diffuse Lewy body-like intracytoplasmic inclusions |
| Q72885207 | Neurofibrillary tangles and Lewy bodies in the locus ceruleus neurons of the aged brain |
| Q35886625 | Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling |
| Q67914362 | Neuronal inclusions of Parkinson's disease |
| Q37693339 | Neuropathological Staging of Brain Pathology in Sporadic Parkinson's disease: Separating the Wheat from the Chaff |
| Q37677151 | Neuropathology of non-motor features of Parkinson disease |
| Q64869820 | Orphan neurones and amine excess: the functional neuropathology of Parkinsonism and neuropsychiatric disease |
| Q92465171 | Parkinson's disease: proteinopathy or lipidopathy? |
| Q69846956 | Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses |
| Q39655523 | Pathogenic lysosomal depletion in Parkinson's disease |
| Q38697214 | Pineal melatonin and sensory symptoms in Parkinson disease |
| Q37299447 | Reduced striatal tyrosine hydroxylase in incidental Lewy body disease |
| Q53126293 | Reduction of Small Fibers of Thoracic Ventral Roots and Neurons of Intermediolateral Nucleus in Parkinson Disease and Dementia with Lewy Bodies. |
| Q52511678 | Substantia nigra degeneration and tyrosine hydroxylase depletion caused by excess S-adenosylmethionine in the rat brain. Support for an excess methylation hypothesis for parkinsonism. |
| Q35950435 | Suppression of α-synuclein toxicity and vesicle trafficking defects by phosphorylation at S129 in yeast depends on genetic context |
| Q38012653 | The Lewy body in Parkinson's disease and related neurodegenerative disorders |
| Q36423369 | The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis |
| Q39463738 | The hypothalamus in Parkinson disease |
| Q40896506 | The hypothalamus in parkinson disease |
| Q89790112 | The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration |
| Q40201701 | Ultrastructural study of a patient with progressive dementia showing special intraplasmic inclusions in diffuse cerebral cortex. Mechanism of inclusions production |
| Q40175949 | Ultrastructure and biochemistry of sympathetic ganglia in idiopathic orthostatic hypotension |
| Q81797017 | [Parkinson's disease, progressive lumbar kyphosis and focal paraspinal myositis] |
| Q24653247 | alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies |